Towards clinical translation of gene editing technologies for empowering adoptive immunotherapy or correcting inherited mutations

被引：0
|
作者：
Genovese, P. [1 ]
机构：
[1] San Raffaele Telethon Inst Gene Therapy, SR Tiget, Milan, Italy
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR63
引用
收藏
页码：A45 / A45
页数：1
相关论文
共 50 条
  • [11] Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
    Ito, Yusuke
    Inoue, Satoshi
    Kagoya, Yuki
    INFLAMMATION AND REGENERATION, 2024, 44 (01)
  • [12] Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
    Yusuke Ito
    Satoshi Inoue
    Yuki Kagoya
    Inflammation and Regeneration, 44
  • [13] Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
    Atsavapranee, Ella S.
    Billingsley, Margaret M.
    Mitchell, Michael J.
    EBIOMEDICINE, 2021, 67
  • [14] Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision Loss
    Botto, Catherine
    Dalkara, Deniz
    El-Amraoui, Aziz
    FRONTIERS IN GENOME EDITING, 2021, 3
  • [15] Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy
    Gautron, Anne-Sophie
    Juillerat, Alexandre
    Guyot, Valerie
    Filhol, Jean-Marie
    Dessez, Emilie
    Duclert, Aymeric
    Duchateau, Philippe
    Poirot, Laurent
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 9 : 312 - 321
  • [16] Towards Clinical Translation of Hematopoietic Cell Gene Editing for Treating Hyper-IgM Type 1
    Vavassori, Valentina
    Mercuri, Elisabetta
    Marcovecchio, Genni
    Castiello, Maria Carmina
    Canarutto, Daniele
    Asperti, Claudia
    Jacob, Aurelien
    Albano, Luisa
    Fontana, Elena
    Scanziani, Eugenio
    Radrizzani, Marina
    Villa, Anna
    Genovese, Pietro
    Naldini, Luigi
    MOLECULAR THERAPY, 2021, 29 (04) : 19 - 19
  • [17] Towards clinical translation of hematopoietic cell gene editing for treating Hyper-IgM Type 1
    Vavassori, V.
    Mercuri, E.
    Marcovecchio, G.
    Castiello, M. C.
    Canarutto, D.
    Asperti, C.
    Jacob, A.
    Albano, L.
    Scanziani, E.
    Radrizzani, M.
    Villa, A.
    Genovese, P.
    Naldini, L.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A69 - A69
  • [18] Towards Clinical Translation of Hematopoietic Cell Gene Editing for Treating Hyper-IgM Type 1
    Vavassori, Valentina
    Mercuri, Elisabetta
    Marcovecchio, Genni
    Castiello, Maria Carmina
    Canarutto, Daniele
    Asperti, Claudia
    Jacob, Aurelien
    Albano, Luisa
    Fontana, Elena
    Scanziani, Eugenio
    Radrizzani, Marina
    Villa, Anna
    Genovese, Pietro
    Naldini, Luigi
    BLOOD, 2021, 138
  • [19] Approaches towards biomaterial-mediated gene editing for cancer immunotherapy
    Shannon, Sydney R.
    Ben-Akiva, Elana
    Green, Jordan J.
    BIOMATERIALS SCIENCE, 2022, 10 (23) : 6675 - 6687
  • [20] Gene editing: Paving the way for accelerated clinical development of adoptive cell immunotherapies
    Heine, P.
    Gee, P.
    Acharya, D.
    Brady, J.
    HUMAN GENE THERAPY, 2019, 30 (11) : A70 - A70
12345